共 101 条
[43]
Kim MS, 2010, CARDIOVASC THER 0409
[45]
Late Safety Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions 2-Year Follow-Up From the ENDEAVOR IV Trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary, Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
[J].
JACC-CARDIOVASCULAR INTERVENTIONS,
2009, 2 (12)
:1208-1218
[48]
Luo Y, 1996, MOL CELL BIOL, V16, P6744